FindTrial
Sign In

P2Y12 inhibitor

DRUG5 trials

Sponsors

UMC Utrecht, ECRI bv, Aggredyne, Inc., Humanitas Hospital, Italy, Insel Gruppe AG, University Hospital Bern

Conditions

Acute Coronary SyndromeAtrial Fibrillation (AF)Community-acquired Pneumonia, Influenza, COVID-19Coronary Artery DiseaseHigh Bleeding RiskOral AnticoagulationP2Y12 InhibitorPCI

Phase 3

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
RecruitingNCT02735707
UMC UtrechtCommunity-acquired Pneumonia, Influenza, COVID-19
Start: 2016-04-11End: 2028-02-29Target: 20000Updated: 2024-07-12

Phase 4

Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPT
NCT03112707
Humanitas Hospital, ItalyAcute Coronary Syndrome, Coronary Artery Disease
Start: 2017-04-14End: 2020-05-01Target: 1023Updated: 2019-08-07
Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
RecruitingNCT05955365
Insel Gruppe AG, University Hospital BernAtrial Fibrillation (AF), Oral Anticoagulation, P2Y12 Inhibitor +1
Start: 2023-12-18End: 2026-12-31Target: 3010Updated: 2024-10-17

Unknown Phase

Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen
CompletedNCT03023020
ECRI bvCoronary Artery Disease, High Bleeding Risk, PCI
Start: 2017-04-04End: 2021-04-30Updated: 2021-08-20
Study of AggreGuide A-100 (ADP) Assay
CompletedNCT03111420
Aggredyne, Inc.Platelet Dysfunction Due to Drugs, Risk Factor, Cardiovascular
Start: 2017-01-09End: 2018-06-30Updated: 2019-02-21

Related Papers

Abbreviated or standard antiplatelet therapy after PCI in HBR patients with chronic kidney disease: a prespecified analysis from the MASTER DAPT trial.
2025-12-01
Early oral anticoagulation monotherapy after PCI: Insights from the POEM trial.
2025-11-19
Recurrent Events Analysis of MASTER DAPT: Total Ischemic and Bleeding Events After Abbreviated vs Prolonged DAPT in HBR Patients.
2025-05-223 citations
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial
Thorax2025-05-139 citations
Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia
Intensive Care Medicine2025-04-0132 citations
Abbreviated or Standard Antiplatelet Therapy After PCI in Diabetic Patients at High Bleeding Risk.
2024-11-017 citations
A blueprint for a multi-disease, multi-domain Bayesian adaptive platform trial incorporating adult and paediatric subgroups: the Staphylococcus aureus Network Adaptive Platform trial.
2023-12-068 citations
Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk
JAMA Cardiology2023-11-2227 citations
Simvastatin in Critically Ill Patients with Covid-19
New England Journal of Medicine2023-10-2559 citations
Intravenous Vitamin C for Patients Hospitalized With COVID-19
JAMA2023-10-2545 citations
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
JAMA2023-04-1166 citations
Abbreviated or Standard Antiplatelet Therapy in HBR Patients: Final 15-Month Results of the MASTER-DAPT Trial.
2023-04-0113 citations
The Relationship Between SARS-CoV-2 Neutralizing Antibody Titers and Avidity in Plasma Collected From Convalescent Nonvaccinated and Vaccinated Blood Donors
The Journal of Infectious Diseases2023-03-274 citations
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19
JAMA2023-03-2192 citations
The Impact of COVID-19 Research on the Development of Scalable Frameworks for Efficient Clinical Trials in Cardiovascular Medicine
Canadian Journal of Cardiology2023-03-153 citations
Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis.
2022-12-0128 citations
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study.
2022-09-2211 citations
Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk.
2022-09-0120 citations
Impact of Medication Nonadherence in a Clinical Trial of Dual Antiplatelet Therapy.
2022-08-0110 citations
Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis
European Heart Journal2022-05-1771 citations

20 more papers not shown